Immunoglobulin News and Research

RSS
BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

4 Apr 2022
What are the long-term symptoms of SARS-CoV-2 infection?

What are the long-term symptoms of SARS-CoV-2 infection?

4 Apr 2022
Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

4 Apr 2022
SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

4 Apr 2022
The effect of COVID-19 on the lung function of young adults

The effect of COVID-19 on the lung function of young adults

3 Apr 2022
Research illuminates why immune disorders affect only one of two identical twins

Research illuminates why immune disorders affect only one of two identical twins

1 Apr 2022
Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

1 Apr 2022
Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

1 Apr 2022
Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

1 Apr 2022
The mucosal antibody response to SARS-CoV-2

The mucosal antibody response to SARS-CoV-2

31 Mar 2022
Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

31 Mar 2022
Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

31 Mar 2022
Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

31 Mar 2022
Prevalence of breastmilk feeding among people with SARS-CoV-2 infection during pregnancy

Prevalence of breastmilk feeding among people with SARS-CoV-2 infection during pregnancy

31 Mar 2022
Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

30 Mar 2022
The potential efficacy of nasal nanoparticle COVID-19 vaccines

The potential efficacy of nasal nanoparticle COVID-19 vaccines

30 Mar 2022
Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

Evaluating serological responses to repeated COVID-19 vaccination in kidney transplant recipients

29 Mar 2022
Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

29 Mar 2022
Natural SARS-CoV-2 antibodies persist for six months in children

Natural SARS-CoV-2 antibodies persist for six months in children

28 Mar 2022
Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

28 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback